Drug Profile
E 5090
Alternative Names: DA E5090Latest Information Update: 28 Nov 1994
Price :
$50
*
At a glance
- Originator Eisai Co Ltd
- Class Anti-inflammatories; Antirheumatics
- Mechanism of Action Immunosuppressants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Rheumatic disorders